Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of posaconazole as prophylaxis for invasive fungal disease
2016-001182-87Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of posaconazole in invasive mycoses, sponsored by Radboud University Medical Center. Primary endpoint: Primary pharmacokinetic comparison. Started Jul 2016; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2016-001182-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001182-87.